Mantle Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mantle Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating Bryostatin-1 in combination with vincristine for progressive or relapsed non-Hodgkin lymphoma after bone…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of gossypol, paclitaxel, and carboplatin in patients with metastatic or unresectable solid tumors, …
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function [Phase 1]
Phase 1 trial of sorafenib in patients with metastatic or unresectable solid tumors, multiple myeloma, or non-Hodgkin lymphomas; the study h…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy [Phase 2]
Phase 2 trial of everolimus in older patients with mantle cell lymphoma previously treated with first- or second-line chemotherapy was termi…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma [Phase 2]
Phase 2 SWOG trial S0213 evaluating chemotherapy plus rituximab in mantle cell lymphoma has completed; results were posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating flavopiridol for relapsed mantle cell lymphoma or diffuse large B-cell lymphoma has results posted.
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating Rituximab-Bendamustine-Cytarabine (R-BAC) for mantle cell lymphoma has completed; the update notes the stu…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL [Phase 3]
Phase 3 trial comparing R-CHOP alone versus R-CHOP followed by R-DHAP in untreated mantle cell lymphoma is reporting and updating efficacy d…
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: 131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating 131I-rituximab for relapsed or refractory follicular lymphoma or mantle cell lymphoma is reported; curre…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial of FR901228 (romidepsin) in relapsed or refractory non-Hodgkin's lymphoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma [Phase 2]
Phase II trial of P276-00 for relapsed or refractory mantle cell lymphoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy, bone marrow or peripheral stem cell transplantation, and/or biological therapy f…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma [Phase 2]
Phase 2 trial evaluating gemcitabine for mantle cell lymphoma in patients who are newly diagnosed, relapsed, or chemotherapy-resistant; the …
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating Zevalin-BEAM/BEAC with autologous stem cell support as consolidation in first-line mantle cell lymphoma has compl…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies [Phase 2]
Phase 2 trial of SB1518 in advanced lymphoid malignancies assessed safety and efficacy in Hodgkin lymphoma, mantle cell lymphoma, and indole…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) [Phase 2]
A Phase 2 study of oral panobinostat (LBH589) in relapsed or refractory chronic lymphocytic leukemia and mantle cell lymphoma has been termi…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating temsirolimus (CCI-779) in mantle cell lymphoma, with results…
-
CLINICAL_TRIALS trial_result · 2012-01-02Clinical Trial Update: Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) [Phase 2]
This Phase 2 safety study evaluating induction and consolidation therapy for mantle cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL). [Phase 3]
Phase 3 trial evaluating lenalidomide as maintenance therapy after first-line chemotherapy in mantle cell lymphoma; the study was terminated…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma [Phase 2]
This is a Phase 2 trial evaluating high-dose chemotherapy and stem cell transplantation for mantle cell lymphoma and relapsed low-grade non-…
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma [Phase 2]
Phase 2 study of Zevalin (yttrium-ibritumomab tiuxetan) for relapsed or refractory mantle cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies [Phase 2]
Phase II study assessing AT-101 as a single-agent therapy in relapsed or refractory B-cell malignancies has completed, reporting safety and …
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma [Phase 2]
The National Cancer Institute completed a Phase 2 trial of tanespimycin (17-AAG) in relapsed or refractory Anaplastic Large Cell Lymphoma, M…
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 study evaluating oblimersen sodium in combination with rituximab for recurrent B-cell non-Hodgkin lymphoma completed, with results…